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Abstract
Introduction
Positron Emission Tomography (PET) imaging with selective 18 kDa translocator protein
(TSPO) radiotracers has contributed to our understanding on the role of inflammation in dis-
ease development and progression. With an increasing number of rodent models of human
disease and expansion of the preclinical PET imaging base worldwide, accurate quantifica-
tion of longitudinal rodent TSPO PET datasets is necessary. This is particularly relevant as
TSPO PET quantification relies on invasive blood sampling due to lack of a suitable tissue
reference region. Here we investigate the kinetics and quantification bias of a novel TSPO
radiotracer [18F]AB5186 in rats using automatic, manual and image derived input functions.
Methods
[18F]AB5186 was administered intravenously and dynamic PET imaging was acquired over
2 hours. Arterial blood was collected manually to derive a population based input function or
using an automatic blood sampler to derive a plasma input function. Manually sampled
blood was also used to analyze the [18F]AB5186 radiometabolite profile in plasma and
applied to all groups as a population based dataset. Kinetic models were used to estimate
distribution volumes (VT) and [18F]AB5186 outcome measure bias was determined.
Results
[18F]AB5186 distribution in rats was consistent with TSPO expression and at 2 h post-injec-
tion 50% of parent compound was still present in plasma. Population based manual sam-
pling methods and image derived input function (IDIF) underestimated VT by ~50% and
88% compared with automatic blood sampling, respectively. The VT variability was lower
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when using IDIF versus arterial blood sampling methods and analysis of the Bland-Altman
plots showed a good agreement between methods of analysis.
Conclusion
Quantification of TSPO PET rodent data using image-derived methods, which are more
amenable for longitudinal scanning of small animals, yields outcome measures with reduced
variability and good agreement, albeit biased, compared with invasive blood sampling
methods.
Introduction
The 18 kDa translocator protein (TSPO), previously known as the peripheral benzodiazepine
receptor, is a five-membrane domain protein expressed in the outer membrane of the mito-
chondria of different cell types present in peripheral tissues and the central nervous system
(CNS). In the periphery, high TSPO levels are reported in immune cells, including macro-
phages [1–3]. In the CNS, high levels of TSPO are associated with activated microglia and
astrocytes [4–8]. At the organ level, the highest expression of TSPO is reported in the lungs
and in the heart, and low levels are present in the healthy brain [9,10].
Given the expression of TSPO in immune cells, TSPO imaging is an attractive target for
Positron Emission Tomography (PET) imaging of inflammation. To date, TSPO PET imaging
has been used to non-invasively investigate regional inflammatory responses in a wide array of
human diseases, including Parkinson’s disease [11], Alzheimer’s disease [12], traumatic brain
injury [13], stroke[14], myocardial infarction [15] and atherosclerosis [1,2]. Moreover, over
the past few years, translational TSPO small animal PET imaging has rapidly expanded due to
increasing availability of rodent models of human disease and preclinical PET scanners. TSPO
radiotracers have progressively been used to interrogate disease development and progression,
as well as treatment response in rodents.
Despite the translational value of TSPO PET imaging in multiple diseases, TSPO radiotrac-
ers developed to date have suboptimal properties, hampering their widespread clinical use.
11C-PK11195 was the first radiotracer to be used consistently for in vivo imaging of inflamma-
tion using PET, but has high levels of non-specific binding[16], high plasma protein binding
[17] and a short physical half-life due to carbon-11 (20 minutes). Second generation TSPO
ligands (e.g. [11C]PBR028 and [18F]PBR111) display large interindividual variability in binding
affinity in humans, which has been attributed to a human genetic polymorphism [18]. The
limitations of previously developed TSPO radiotracers have led to multiple research groups,
including ourselves, to work on developing new libraries of novel compounds targeting TSPO.
In addition to difficulties in generating a TSPO radiotracer with optimal properties for in
vivo imaging of humans, TSPO PET imaging is also devoid of a good tissue reference region
for simplified quantification of data. As such, absolute quantification relies typically on the use
of invasive blood input functions. This characteristic can pose limitations to clinical imaging
with TSPO radiotracers, and the problem is further complicated when imaging small animals,
owing to the small size and limited blood volume of rodents.
Therefore, studies investigating the quantitative bias of different TSPO PET data analysis
approaches (invasive versus non-invasive) in small animals would inform on optimal protocols
to better evaluate changes in TSPO expression in rodent models of disease, as well as measure-
ment of new radiotracers and drugs performance with TSPO PET imaging. Recently we
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developed [18F]AB5186, a promising novel TSPO radiotracer, and assessed its in vivo perfor-
mance in a rodent model of glioblastoma and in the brain of a baboon [17]. This radiotracer
displayed good brain imaging properties similar to other TSPO PET radiotracers currently in
preclinical and clinical use. The present study aimed to assess the quantification bias in small
animal PET kinetic modelling studies using [18F]AB5186 and invasive versus non-invasive
quantification methods, and specifically to compare the most widely reported methods for
generation of an input function in rodent PET studies (image derived and population curves)
with invasive and continuous automatic blood sampling.
Materials and methods
Radiotracer preparation
AB5186 precursor and standard were prepared from 2-aminobenzophenone and diethyl acety-
lenedicarboxylate in five and six steps, respectively, as described in S1 Data. [18F]AB5186 was
prepared by reacting 3-chloromethyl-4-phenylquinoline-2-N-diethylcarboxamide precursor
with 18F-fluoride in the presence of potassium carbonate and Kryptofix 222 at 100˚C for 10
min (Fig 1), using a commercial synthesizer, GE TRACERlab FX-FN. The radiolabeled product
was purified by semi-preparative High-Performance Liquid Chromatography (HPLC) using
the following conditions: C18 Synergi Hydro-RP 80Å, 150×10mm, 4μm column (Phenom-
enex, UK), acetonitrile/water (70:30 v/v) and flow rate of 3 mL/min. The final product was for-
mulated in a physiological solution containing 10% ethanol in normal saline. [18F]AB5186 was
obtained with an average activity yield of 31% (starting from 15±6 GBq of 18F-fluoride, n = 14)
after a total synthesis time of 50 minutes. Identity of [18F]AB5186, radiochemical purity
(>99%) and specific activity (495–900 GBq/μmol; 13–24 Ci/μmol, n = 6) were determined by
analytical HLPC at the end of the synthesis using the following conditions: C18 Synergi
Hydro-RP 80 Å, 250×4.6 mm, 4μm column (Phenomenex, UK), acetonitrile/water (70:30 v/v),
flow rate of 1 mL/min and ultraviolet absorbance at λ = 267 nm.
Animals and surgical procedures
All experiments were conducted in accordance with the local University of Edinburgh animal
ethics committee and were authorized by the Home Office under the Animals (Scientific Pro-
cedures) Act 1986. Thirteen adult male Sprague-Dawley rats (416±79g and 11.0±0.3 weeks)
were used for this study. The animals were housed under standard 12 h light:12 h dark condi-
tions with food and water available ad libitum. On the day of the experiment, anesthesia was
induced and maintained with 1.5–2.5% isoflurane (50/50 oxygen/nitrous oxide, 1 L/min). At
the end of experiments animals where euthanized by overdose of anesthesia followed by
Fig 1. [18F]AB5186 radiosynthesis.
https://doi.org/10.1371/journal.pone.0217515.g001
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confirmation of death using a schedule 1 method (cervical dislocation). For imaging experi-
ments, an intravenous (i.v.) line was established in the femoral vein or tail vein for injection of
the radiotracer and the femoral artery was cannulated to allow automated blood sample collec-
tion, as previously described [19]. On a separate set of experiments (radiometabolite studies),
the femoral artery was cannulated for blood sampling and the radiotracer was administered
i.v. via tail vein. Surgical cannulation of femoral vein and artery was performed as follows:
polyethylene catheters (PE50) filled with heparinized saline (20 IU/mL) were inserted into the
left femoral artery or vein with the help of a stereomicroscope and securely fastened with liga-
tures (6–0 silk thread). Catheters were held in place with surgical glue. Body temperature was
maintained by heated scanner bed or heated mat and monitored by rectal thermometer. Vital
signs, including heart rate and respiration rate were monitored continuously during the
experiments.
PET studies
Study design. PET scans were performed immediately following intravenous bolus injec-
tion of [18F]AB5186 (mean injected radioactivity of 27.87±2.51 MBq, mean±SD, n = 3) via the
femoral vein shunt set-up for automatic blood sampling, as previously described [19]. PET
dynamic imaging data collected as part of these kinetic modelling experiments were modelled
using three different input function methods: (Group 1) automatic blood sampling with the
Swisstrace system for each individual animal scanned (gold-standard method), (Group 2)
manual blood sampling through the femoral artery to create a population curve from various
animals as well as to derive a radiometabolite population curve data (sampling details below),
and (Group 3) image derived input function from the left ventricle VOI for each individual
animal scanned. All input functions were modelled using the population radiometabolite
curve.
Image acquisition and reconstruction. All PET data were acquired using a microPET/
CT animal scanner (nanoPET/CT, Mediso, Hungary). A CT scan (semi-circular full trajectory,
maximum field of view, 480 projections, 50 kVp, 300 ms and 1:4 binning) was acquired for
attenuation correction. Immediately following radiotracer administration, a 120 minutes emis-
sion scan was obtained using 3-dimentional 1:5 mode and re-binned as follows: 18×10sec;
2×30sec; 1×60sec; 2×2min; 10×5min; 6×10min. PET images were reconstructed using Medi-
so’s iterative Tera-Tomo OSEM 3D reconstruction algorithm and the following settings: 4 iter-
ations, 6 subsets, full detector model, low regularization, spike filter on, voxel size 0.4 mm and
400–600 keV energy window. PET data were corrected for randoms, scatter and attenuation.
Image processing. Reconstructed scans were imported into PMOD 3.8 software (PMOD
Technologies, Switzerland). Volumes of interest (VOIs) were manually drawn around lungs,
heart and brain; and a 1 mm radius sphere (equivalent to 4.18 mm3 and within acceptable
range given the PET scanner resolution of 0.7 mm) was used as blood pool and placed inside
the left ventricle. The VOI rat brain template (W. Schiffer) [20] available on PMOD was used
for PET image co-registration and VOI placement for quantification of regional brain radio-
tracer uptake kinetics. Average images of [18F]AB5186 PET data were generated by averaging
frames with highest brain uptake (0–30 min post-radiotracer administration for all subjects).
Then, the average image was co-registered to the rat MRI template available in PMOD using
rigid manual matching. The transformation matrix was saved and subsequently applied to the
dynamic PET series. Finally, template VOIs were applied to the co-registered PET images for
image quantification. The following template brain regions were analyzed: striatum, frontal
association cortex, medial prefrontal cortex, orbitofrontal cortex, enthorhirnal cortex, hypo-
thalamus, thalamus, midbrain, cerebellum white matter and cerebellum grey matter.
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Data analysis. Time-activity curves (TACs) were generated and standardized uptake val-
ues (SUVs) calculated as concentration in the VOI divided by injected dose divided by animal
weight.
Kinetic modelling was performed using 2-Tissue compartmental analysis (2T model) and
Logan graphical analysis to estimate the volume of distribution (VT) in different brain regions,
as well as heart and lungs [21,22]. For kinetic modelling analysis using input function derived
from population curves (manual sampling methods), the whole blood and plasma values per
subject were all corrected for differences in injected dose, in order to derive meaningful out-
come measures. The Akaike selection criteria (AIC) for different models was outputted and
the selected kinetic model identifiability criterion was the percentage standard error (%SE) of
VT estimates. The typical error of measurement (TEM) for each method of analysis was calcu-
lated as TEM = SD/SQR(2) and the coefficients of variation (COV) were estimated as COV =
(SD/Mean)�100. Bland-Altman plots were calculated as previously described [23,24].
Arterial input functions using the automatic blood sampler
A commercially available automatic blood sampling system (Twilite2, Swisstrace, Switzerland)
was used for the measurement of blood radioactivity (Group 1) as previously described [19].
This system allows for whole-blood arterial input function measurements with a temporal res-
olution of 1 second and without blood loss due to surgically induced arteriovenous shunt.
With data acquired in separate studies, the whole-blood arterial input function measured by
the automatic blood sampler was corrected for the plasma-to-whole blood ratio and for metab-
olism in vivo (details in section below).
Radiometabolite and arterial blood processing and analysis
Arterial blood samples were collected at 2, 5, 10, 20, 30, 60 and 120 minutes post-radiotracer
administration (65.28±28.37 MBq, mean±SD, n = 10). Brain and heart samples were collected
at 120 min post-injection. All blood samples were 1–2 mL each and manually collected from
different animals to generate a population curve (n = 3 for each time point), in order to respect
total blood volume limits for terminal arterial blood collections in rats. Following blood and
tissue collection, all samples were kept on ice until analyzed. Radioactivity in whole blood and
plasma was assessed using a well-type γ-counter using a 400–1400 keV window (Perkin Elmer
Wizzard2, USA) and used as the input function for Group 2. Brain and heart tissue samples
were homogenized, then radioactivity measured in the well-type γ-counter. Plasma samples
(400 μL) and tissue samples (2 mL) were processed by acetonitrile denaturation (ratio of 1:1.4)
and analyzed by HPLC (Untimate2000, ThermoFisher, UK) on a Luna C18(2) column (Luna
C18(2), 10×250 mm, 10 μm, Phenomenex, UK) with a mobile phase of acetonitrile/water 70/
30 at a flow rate of 4 mL/min to estimate the parent fraction. The plasma protein binding free
fraction (fp) was determined using ultrafiltration units (Centrifree 30K, Millipore, UK).
Results
PET studies in rats showed that, following intravenous (i.v.) bolus injection, [18F]AB5186 rap-
idly entered the brain with peak SUV in whole brain of 0.83±0.05 g/mL (mean±SD, n = 3) and
displayed a distribution consistent with known TSPO expression, being highest in the heart
and lungs (5.92±0.24 g/mL and 4.87±1.93 g/mL, respectively, mean±SD, n = 3) and lowest in
the brain (Fig 2). The radiotracer uptake profile was consistent with reversible binding kinet-
ics. Regional TACs in whole organs and brain regions following i.v. bolus of [18F]AB5186 are
shown in Fig 2C and 2D, respectively.
Quantification bias TSPO PET rodent data
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Post-i.v. bolus injection, a rapid clearance of [18F]AB5186 in rat blood was measured by
automatic blood sampling and manual population based time-point sampling (Fig 3A). The
image derived input function (VOI in left ventricle) showed similar peak uptake kinetics, but
slower plateau kinetics, compared with invasive methods of arterial input function sampling.
Fig 2. Distribution and kinetics of [18F]AB5186 in rats. (a) Representative PET sum images of [18F]AB5186 at different times points
showing distribution of novel radiotracer in rat brain and (b) heart and lungs. PET images co-registered with CT images. Average SUV
TACs in brain, heart, lungs and blood pool (c), as well as, different brain regions (d) following bolus intravenous injection of [18F]
AB5186. Note reversible tissue kinetics of novel TSPO PET radiotracer. Data presented as mean±SEM, n = 3.
https://doi.org/10.1371/journal.pone.0217515.g002
Quantification bias TSPO PET rodent data
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Metabolism of the novel radiotracer measured by high performance liquid chromatography
(HPLC) showed a relatively slow in vivo metabolism of [18F]AB5186 in blood (Fig 3B) and at 2
h post-injection, 50.31±14.92% (mean±SD, n = 3) of parent was detected in plasma (S1 Fig).
No radiometabolites were detected in brain and heart tissue samples 2 h post-injection (S1
Fig). The measured free fraction in plasma (fp) of [18F]AB5186 was 6.73±0.01% (mean±SD,
n = 3).
When using the arterial input function obtained with the automatic blood sampler (Group
1), both kinetic modelling methods of analysis (2T and Logan with t� = 25 minutes) were
found to fit the data (Table 1), although Logan was able to estimate VT with the lowest %SE
(average of 35.7% for 2T and 2.6% for Logan plot) of investigated models (Table 1) albeit with
higher Akaike selection criteria (average 99 for 2T versus 131 for Logan plot, S1 Table). The 2T
modelling VT were higher than Logan invasive by ~7–50% (Fig 4). When using the population
arterial input function obtained with the manual time-points sampling method (Group 2) and
non-invasive image derived input function (Group 3), only Logan was able to fit all regions.
The VT from Group 2 were underestimated by ~48–41% compared with Logan VT determined
using the automatic blood sampling method and the Logan plot (Fig 4). The use of non-inva-
sive image derived input function (Group 3) underestimated Logan VT by ~88–87% compared
with automatic blood sampling input function method (Fig 4). The quantitative underestima-
tion biases were more pronounced in the brain compared with peripheral organs (Fig 4B ver-
sus A). Despite measured biases, VT determined using Logan plot in Group 2 and Group 3
were highly correlated with Group 1 (r2>0.9). As shown in the Bland-Altman plot in Fig 5,
there is only one to two outlying measurements for heart (Fig 5A and 5B), cerebellum white
matter and frontal association cortex (Fig 5D–5F) across all measurement comparisons. This
may be due to poor identifiability of the parameters of the 2T (heart) and Logan (cerebellum
Fig 3. Concentration of [18F]AB5186 and parent fraction in rat whole blood and plasma. Normalised measured radioactive concentration in whole blood
and plasma using different sampling methods (a) and parent fraction profile in plasma over time following bolus intravenous injection of [18F]AB5186. The
insert graph shows the same data between 0–10 minutes. (b). Automatic whole blood and plasma refer to measurements using the automatic blood sampler
system. Manual whole blood and plasma refer to measurements using manual sampling of arterial blood. All data has been normalized relative to injected dose,
so that the different whole blood and plasma curves can be compared with each other. Data presented as mean±SEM, n = 3.
https://doi.org/10.1371/journal.pone.0217515.g003
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white matter and frontal association cortex) models, which results in unreasonably high value
for those VOIs VT and thus may cause deterioration of the overall test-retest metrics. Further-
more, the calculated TEM was lowest for Group 3 (non-invasive image derived input function)
independently of inclusion/exclusion of peripheral organs (Fig 6A and 6B, respectively). The
%COV was highest for Group 1 (automatic blood sampling) when 2T was used for quantifica-
tion of VT and similar across all groups when Logan graphical analysis was used to estimate VT
(Fig 6C and 6D).
Table 1. [18F]AB5186 kinetic modelling results obtained using 2T compartmental model and Logan graphical analysis with various methods used to derive the
input function (mean±SEM, n = 3).
Region/ Tissue VT− 2T Group 1 VT—Logan Group 1 VT—Logan Group 2 VT—Logan Group 3
Mean±S.E.M. % SE±S.E.M Mean±S.E.M. % SE±S.E.M Mean±S.E.M. % SE±S.E.M Mean±S.E.M. % SE±S.E.M
Heart 26.89± 3.17 1.50± 0.24 24.98± 2.85 0.36± 0.07 13.27± 1.11 0.29± 0.09 5.82± 0.20 0.20± 0.07
Lungs 7.08± 0.32 16.56± 7.90 6.95± 0.47 0.28± 0.12 3.74± 0.39 0.43± 0.18 1.64± 0.19 0.76± 0.16
Whole Brain 3.75± 0.86 15.38± 6.51 3.32± 0.51 2.41± 0.33 1.79± 0.33 2.91± 0.15 0.76± 0.14 3.36± 0.34
Striatum 2.53± 0.56 14.87± 4.11 2.39± 0.40 2.09± 0.27 1.28± 0.25 2.57± 0.35 0.55± 0.10 2.65± 0.33
Frontal Association Cortex 4.23± 1.46 32.96± 8.10 4.07± 0.86 8.67± 2.03 2.20± 0.54 9.00± 1.56 0.94± 0.22 8.30± 2.20
Medial Prefrontal Cortex 3.51± 1.72 223.80± 198.12 2.18± 0.36 2.90± 0.87 1.18± 0.23 3.21± 0.61 0.51± 0.10 3.14± 0.97
OrbitoFrontal Cortex 4.24± 0.69 32.22± 9.22 3.59± 0.64 3.57± 0.33 1.94± 0.41 4.04± 0.39 0.83± 0.18 4.04± 0.40
Enthorhirnal Cortex 6.16± 1.06 40.40± 8.62 4.13± 0.56 3.91± 0.17 2.23± 0.37 4.54± 0.53 0.93± 0.17 4.81± 0.17
Hypothalamus 2.98± 0.38 23.06± 6.94 2.86± 0.33 2.12± 0.15 1.54± 0.23 2.57± 0.53 0.66± 0.10 2.65± 0.18
Thalamus 2.44± 0.43 13.72± 2.11 2.49± 0.39 1.47± 0.47 1.34± 0.25 1.83± 0.30 0.58± 0.10 2.10± 0.47
Midbrain 2.63± 0.64 27.25± 17.32 2.48± 0.38 1.77± 0.63 1.34± 0.25 2.12± 0.40 0.58± 0.10 2.45± 0.67
Cerebellum White Matter 3.35± 0.62 11.45± 5.00 3.25± 0.41 1.79± 0.40 1.75± 0.27 2.23± 0.44 0.75± 0.11 2.50± 0.40
Cerebellum Grey Matter 3.94± 0.94 11.22± 3.56 4.20± 0.92 2.79± 0.61 2.03± 0.42 2.95± 0.35 0.86± 0.16 3.34± 0.53
VT, total distribution volume. SEM, standard error of the mean. SE, standard error. Group 1, Swisstrace input function (automatic blood sampling). Group 2, manual
input function. Group 3, image derived input function.
https://doi.org/10.1371/journal.pone.0217515.t001
Fig 4. Comparative analysis betweenVT obtained using 2T model and Logan graphical analysis with different input functions for all tissues (a) and
brain regions only (b). Note strong correlation despite bias of manual sampling and image derived input functions relative to automatic blood sampler. IDIF,
image derived input function.
https://doi.org/10.1371/journal.pone.0217515.g004
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Discussion
This study investigated the quantification bias of kinetic modelling outcome measures of
rodent TSPO PET when using image derived input function versus two invasive blood sam-
pling methods. To our knowledge, this is the first study to date investigating such quantifica-
tion bias of a TSPO PET radiotracer in rodents. Results collected here showed that [18F]
AB5186 has a consistent distribution with TSPO expression [9,10] and comparable outcome
measures to other previously developed radiotracers. For example, injection of [11C]PK11195
into naïve Sprague-Dawley rats yielded a VT in brain of 3.2 mL/cm3 [25], versus our [18F]
AB5186 estimated VT in brain of 3.3 mL/cm3 using the automatic blood sampling invasive
quantification methods. Metabolism of [18F]AB5186 in rat blood was slower than other previ-
ously developed TSPO radiotracers in rats, namely [18F]DPA-714 [26], [18F]GE180 [27] and
[11C]DPA-713 [28].
The pharmacokinetics of [18F]AB5186 were reversible and could be described by both the
2T model and the invasive Logan graphical analysis when using automatic blood sampling
methods (Group 1). The Logan plot was able to fit all regions for Groups 1 to 3 (with lowest %
SE), while 2T was only able to fit the data for Group 1, thus and despite higher AIC compared
with 2T invasive, the Logan plot was the preferred model to describe [18F]AB5186 PET data
and allow comparison of study Groups. This is likely due to two main factors: (1) poorly
described arterial input function when using population manual sampling approaches, where
peak definition is suboptimal; and (2) substantial noise and spill-over issues with image
derived input function. Manual sampling methods (Group 2) and image derived input func-
tion methods (Group 3) underestimated VT by approximately 50% and 88% compared with
automated sampling, respectively. The underestimation bias of image derived input function
observed is likely due to poor blood pool VOI spill over ratios, which deteriorate over time due
to radiotracer uptake in surrounding heart tissue. Moreover, sampling requirements for
Fig 5. Bland-Altman plots assessing agreement between 2T model and Logan graphical analysis in all tissues with different input functions methods.
Group 1 (Logan) and Group 1 (2T) (a); Group 1 (Logan) and Group 2 (Logan) (b); and Group 1 (Logan) and Group 3 (Logan) (c). This was also carried out
using only brain regions for Group 1 (Logan) and Group 1 (2T) (d); Group 1 (Logan) and Group 2 (Logan) (e); and Group 1 (Logan) and Group 3 (Logan) (f).
https://doi.org/10.1371/journal.pone.0217515.g005
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dynamic image-derived input function can impact on accurate description of peak input func-
tion (fast perfusion phase) [29] and this is particularly troublesome in small animal PET imag-
ing, owing to the fast heart rate (c. 300–400 bpm) and limited count rate statistics.
Previous studies in mice and rats with [18F]FDG have shown that the choice of the blood
pool VOI placement (e.g. left ventricle and inferior vena cava) has a profound effect on kinetic
outcome measures [30,31]. From those studies, the use of the inferior vena cava was proposed
as a reliable and reproducible image derived input function method for [18F]FDG kinetic
modelling in mice, even without partial-volume corrections. Albeit useful in mice PET studies,
as the whole body is in the field of view of preclinical PET systems, the use of the vena cava
would be of limited value when collecting dynamic PET data in rats owing to limited size of
most scanners field of view and larger animal body size. This is particularly critical when con-
ducting dynamic brain PET studies. The use of the left ventricle blood pool VOI is, therefore, a
straightforwardly available option for dynamic PET rat studies of the thorax and brain.
Importantly, Fang and Muzic Jr have shown that, when the blood pool VOI was placed
inside the left ventricle (similar to our study with [18F]AB5186), the spillover and partial-vol-
ume effects of image derived input functions in mice and rats following intravenous injection
of [18F]FDG could be corrected by a physiological model-corrected input function [32]. This
model was able to reduce errors on absolute kinetic modelling outcome measures by at least a
10-fold factor. It is foreseeable that such a method could be equally applied to TSPO PET imag-
ing studies in rodents to reduce errors in the image derived input function method. TSPO is
expressed in tissue throughout the body [33], and as a result the use of a reference region such
as skeletal muscle is inappropriate. As a result, this study made use of a blood pool VOI.
Fig 6. Calculated typical error of measurement (TEM) and coefficients of variation (COV). (a) TEM of tissues and (b) brain regions for all methods
investigated. (c) %COV of tissues and (d) brain regions for all methods investigated. G1 = group 1 (automatic blood sampling), G2 = group 2 (manual
sampling) and G3 = group 3 (image derived input function).
https://doi.org/10.1371/journal.pone.0217515.g006
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Conceptually, manual arterial blood sampling methods are considered the gold standard
for input function determination, as these unlike original automatic sampling methods are not
affected by dead volume issues and background subtraction problems [34,35], nor are these
affected by spill-over ratio errors associated with image derived methods. However, in small
animals, arterial manual sampling techniques are impractical owing to small blood volume of
rodents, and the reduction of blood volume required to derive a good quality input function
may influence the animal’s physiology [36]; which consequently could impact on radiotracer
uptake kinetics. Therefore, the use of a population average input function for rodent PET data
quantification has been suggested as an alternative approach to single animal manual sampling
methods [37]. Using [18F]FDG in mice, Meyer et al. demonstrated that population average
input functions can result in large errors in individual animal quantification (30 to 50%), thus
introducing variability on PET outcome measures. In this study with [18F]AB5186 in rats, we
found a bias of approximately 50% when using manual sampling methods (population based)
relative to automatic blood sampling methods (individual animal based). This agrees with
results from Meyers et al., despite the differences in radiotracer used and animal species, sug-
gesting this might be a fundamental methodological issue rather than radiotracer specific
variability.
With the recent development of improved automatic blood samplers [19], the main original
issues with this technology (namely, dead volume issues and background subtraction problems)
have been resolved. Still, this method requires surgical cannulation and an arterial-venous
shunt; deeming this a suboptimal approach for multiple-point longitudinal scanning of small
animals. In this study, we have found that, despite measured bias of different input function
methods, there was a strong correlation of the kinetic outcome measures determined using
image derived methods versus manual sampling versus automatic blood sampling methods.
Moreover, on average, the VT variability per group (assessed by TEM) was lower when using
image derived input functions compared with automatic sampling or manual sampling. This is
likely due to blood measurement errors leading to an increase of variability when using invasive
methods versus in-study/subject image derived input functions. Consequently, the least invasive
approach of image-derived input function seems acceptable for quantification of rodent TSPO
PET studies. Importantly, the %COV was consistent across all groups when using Logan graphi-
cal analysis, thus indicating image derived input function can produce reliable data with similar
variation in the outcome measures; albeit biased relative to invasive methods.
Conclusions
Quantification of TSPO PET rat data using [18F]AB5186 can be achieved using image derived
input function methods with a VOI placed inside the left ventricle. Despite bias relative to
invasive methods of quantification, outcome measures obtained using image derived input
functions are robust, strongly agree with outcome measures from invasive methods, are less
variable and potentially more amenable for longitudinal scanning of small animals. These
results may encourage others to undertake kinetic modelling of rodent PET data due to the
suitability and feasibility of image derived input functions.
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